Combined heart and kidney transplantation: long-term analysis of renal function and major adverse events at 20 years

G Bruschi1, L Botta, T Colombo

  • 1Cardiology & Cardiac Surgery Department A De Gasperis, Niguarda Ca' Granda Hospital, Milan, Italy. giuseppe.bruschi@fastwebnet.it

Insights

Combined heart-kidney transplantation (HKTx) offers good long-term outcomes for patients with end-stage heart and kidney failure. This procedure demonstrates satisfactory results with few complications in selected candidates.

Area of Science:

  • Nephrology
  • Cardiology
  • Transplantation Medicine

Background:

  • Combined heart-kidney transplantation (HKTx) is a viable treatment for patients with end-stage heart disease and severe kidney dysfunction.
  • This study reports on the long-term follow-up of patients undergoing this combined procedure.

Purpose of the Study:

  • To evaluate the long-term efficacy and safety of combined heart-kidney transplantation (HKTx).
  • To assess patient survival and allograft outcomes following HKTx.

Main Methods:

  • A retrospective analysis of nine patients who underwent simultaneous HKTx between April 1989 and November 2009.
  • Patient demographics, perioperative course, and long-term outcomes including survival and graft function were reviewed.

Main Results:

  • The majority of patients (7/9) were male, with seven requiring dialysis pre-transplant.
  • One patient died early (41 days post-transplant); three late deaths occurred due to infection, neoplasm, and stroke.
  • Only one patient experienced renal allograft failure at 10 years; others maintained good estimated glomerular filtration rates (eGFR).

Conclusions:

  • Combined HKTx is a successful strategy for selected patients with combined cardiac and renal end-stage failure.
  • The procedure yields satisfactory short- and long-term results with a low complication rate for both cardiac and renal allografts.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...